Ranbaxy consolidated net loss at Rs 73.60 cr in Jan-Mar qtr
Drug maker Ranbaxy Laboratories today reported a consolidated net loss of Rs 73.60 crore during the January-March quarter of 2013-14.
The Gurgaon headquartered firm had posted net profit of Rs 125.75 crore during the corresponding quarter of previous fiscal.
During the quarter under review, Ranbaxy's consolidated revenues increased by 1.2 per cent to Rs 2,436.1 crore, against Rs 2,411.10 crore in the year-ago period.
During the quarter this year, the company recorded inventory and other costs write-off and goodwill impairment write-off of Rs 15.90 crore and Rs 43.80 crore, respectively.
The company has changed its accounting year from January-December (calendar year) to April-March (financial year). Thereby, the current accounting year is for a period of 15 months.
Ranbaxy has posted a net loss of Rs 1085.25 crore for the 15 months ended March 31.
(Posted on 10-05-2014)